Patricia Carr, SVP, Chief Accounting Officer at Jazz Pharmaceuticals plc (JAZZ), sold 53 shares at $122.49 ($6K) on 2024-12-02, disclosed to the SEC on 2024-12-04.
Open-market sale of $6k JAZZ by SVP, Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| JAZZ | SELL | 2025-12-09 | $798K | — | Filing → |
| JAZZ | SELL | 2025-11-20 | $1.9M | — | Filing → |
| JAZZ | SELL | 2025-03-11 | $314K | — | Filing → |